Log in

CVE:SQDSQI Diagnostics Stock Price, Forecast & News

C$0.18
+0.01 (+2.78 %)
(As of 05/27/2020 01:36 AM ET)
Add
Compare
Today's Range
C$0.18
Now: C$0.19
C$0.19
50-Day Range
C$0.10
MA: C$0.14
C$0.19
52-Week Range
C$0.05
Now: C$0.19
C$0.20
Volume49,050 shs
Average Volume375,678 shs
Market CapitalizationC$51.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. SQI Diagnostics Inc. has a co-develop and licensing agreement with McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing; and research and development agreements with University Health Network to create and license rapid multiplexed protein assays, as well as a point-of-care diagnostic device to enable transplant surgeons assess the suitability of lungs and other organs for transplantation. The company was founded in 1999 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6749500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.81 million
Cash FlowC$0.01 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

Employees42
Market CapC$51.21 million
Next Earnings Date5/28/2020 (Estimated)
OptionableNot Optionable

Receive SQD News and Ratings via Email

Sign-up to receive the latest news and ratings for SQD and its competitors with MarketBeat's FREE daily newsletter.

SQI Diagnostics (CVE:SQD) Frequently Asked Questions

How has SQI Diagnostics' stock been impacted by COVID-19 (Coronavirus)?

SQI Diagnostics' stock was trading at C$0.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SQD stock has increased by 146.7% and is now trading at C$0.19. View which stocks have been most impacted by Coronavirus.

When is SQI Diagnostics' next earnings date?

SQI Diagnostics is scheduled to release its next quarterly earnings announcement on Thursday, May 28th 2020. View our earnings forecast for SQI Diagnostics.

How were SQI Diagnostics' earnings last quarter?

SQI Diagnostics Inc. (CVE:SQD) posted its quarterly earnings data on Thursday, February, 27th. The company reported ($0.01) EPS for the quarter. The business earned $0.21 million during the quarter. View SQI Diagnostics' earnings history.

Has SQI Diagnostics been receiving favorable news coverage?

Media stories about SQD stock have trended negative on Wednesday, according to InfoTrie. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. SQI Diagnostics earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutSQI Diagnostics.

Who are some of SQI Diagnostics' key competitors?

What other stocks do shareholders of SQI Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SQI Diagnostics investors own include Cigna (CI), Global Payments (GPN), AlarmCom (ALRM), Brookfield Asset Management (BAM.A), Baxter International (BAX), Becton Dickinson and (BDX), Charter Communications (CHTR), Costco Wholesale (COST), Canadian Tire (CTC.A) and CytRx (CYTR).

Who are SQI Diagnostics' key executives?

SQI Diagnostics' management team includes the following people:
  • Mr. Andrew Morris, CEO, Pres & Director (Age 53)
  • Ms. Patricia Lie CPA, CA, VP of Fin. & Admin.
  • Dr. Eric Brouwer, Chief Scientific Officer
  • Dr. Peter Lea Ph.D., Founder (Age 74)
  • Mr. Russell Peloquin, VP of Global Commercial Operations

What is SQI Diagnostics' stock symbol?

SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."

How do I buy shares of SQI Diagnostics?

Shares of SQD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is SQI Diagnostics' stock price today?

One share of SQD stock can currently be purchased for approximately C$0.19.

How big of a company is SQI Diagnostics?

SQI Diagnostics has a market capitalization of C$51.21 million and generates C$1.81 million in revenue each year. SQI Diagnostics employs 42 workers across the globe.

What is SQI Diagnostics' official website?

The official website for SQI Diagnostics is sqidiagnostics.com.

How can I contact SQI Diagnostics?

SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.